论文部分内容阅读
目的:探讨曲美他嗪治疗老年冠心病稳定型心绞痛的临床效果。方法:将我卫生所收治的76例老年冠心病稳定型心绞痛患者分为对照组(40例)和观察组(36例),前者常规给予常规治疗,后者则是在常规治疗的基础上外加曲美他嗪进行治疗,8周后,比较两组患者的心绞痛和心电图改善情况。结果:观察组的患者在常规治疗的基础上外加曲美他嗪进行治疗,8周后,观察组患者的心绞痛缓解总有效率(94.4%)和心电图缓解总有效率(91.7%)明显高于常规治疗的对照组(77.5%)、(75%)。结论:曲美他嗪联合其他药物治疗老年冠心病稳定型心绞痛疗效显著,值得推广和应用。
Objective: To investigate the clinical efficacy of trimetazidine in the treatment of elderly patients with stable angina pectoris. Methods: 76 cases of elderly patients with coronary heart disease with stable angina pectoris were divided into control group (n = 40) and observation group (n = 36). The former was routinely treated with conventional therapy and the latter with conventional therapy Trimetazidine treatment, 8 weeks later, compared two groups of patients with angina and ECG improvement. Results: The patients in the observation group were treated with trimetazidine on the basis of routine treatment. After 8 weeks, the total effective rate of angina pectoris (94.4%) and the total effective rate of electrocardiogram remission (91.7%) in the observation group were significantly higher than Routine treatment of the control group (77.5%), (75%). Conclusion: Trimetazidine combined with other drugs for the treatment of elderly patients with stable angina pectoris has a significant effect and is worthy of promotion and application.